Clinical Trial Update: Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting pharmacokinetics, pharmacodynamics, and safety of combining arhalofenate with febuxostat in patients with gout and hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Arhalofenate (arhalofenate)
• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Gilead Sciences | Conditions: Gout, Hyperuricemia | Phase 2 | Status: COMPLETED